Ottawa based, Marcan Pharmaceuticals Inc. is a rapidly growing pharmaceutical company actively engaged in the development, marketing, sales and distribution of both brand and generic pharmaceutical products for the Canadian market.
Marcan currently manufactures and distributes a variety of medications covering a wide array of therapeutic categories through numerous dosage forms.
In 2015, Marcan was acquired by Emcure Pharmaceuticals LTD., a vertically integrated global manufacturer and R&D leader. Through optimizing this partnership, Marcan continues to focus on the development and growth of its Canadian portfolio.
IPG- Product development arm of our company founded
Launched 1st Rx product for licensing
Launched 1st first-to-market generic.
Established Marcan Pharmaceuticals Inc. the sales, marketing and distribution arm of the company
Marcan/IPG acquired by Emcure Pharmaceuticals
Launched first alternative dosage product in the form of an injectable.
Continued development of hospital focused portfolio.
Marcan acquired Mantra Pharma
Our mission is to be a leader in supplying innovative, high quality and cost-effective medications to Canadians.
We work closely with organizations engaged in generics related research and development (R&D) as well as decision-makers at grassroots like pharmacy chains to sell quality generics in Canada.
